Article Details

Zacks Investment Research Upgrades Seres Therapeutics (NASDAQ:MCRB) to Hold

Retrieved on: 2021-07-08 10:30:00

Tags for this article:

Click the tags to see associated articles and topics

Zacks Investment Research Upgrades Seres Therapeutics (NASDAQ:MCRB) to Hold. View article details on hiswai:

Excerpt

Several institutional investors and hedge funds have recently added to or reduced their stakes in MCRB. Schroder Investment Management Group ...

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up